The determination of total homocysteine (tHcy) plays an important role in diagnosis and therapy of folate and cobalamin (vitamin B 12 ) deficiencies. In addition, it is now widely accepted that increased tHcy is an independent risk factor for thromboembolism and cardiovascular disease, including coronary occlusive disease (1) (2) (3) .
Although the causal role of Hcy in the development of vascular occlusive disease has yet to be determined, prospective intervention trials that will effectively lower total plasma Hcy currently are in progress (4 ) . As a result, various analytical methods have been established to measure tHcy in serum or plasma (5) (6) (7) (8) (9) (10) . We have established a more rapid protocol suitable for accurately measuring tHcy in hemolysates by use of liquid chromatographyelectrospray ionization-tandem mass spectrometry (LC/ MS/MS). The LC/MS/MS method circumvents the disadvantages of time-consuming derivatization and allows the processing of Ͼ400 samples per day.
Blood was collected in hemolysate tubes that keep the tHcy concentration constant for at least 48 h at room temperature (11 ) . For longer time periods, the hemolysate was stored at Ϫ20°C. Hemolysate (20 L) was pipetted onto filter paper (Neonatal Screening Card; Schleicher & Schuell). For each sample, two spots (equivalent to 4.7 L) were punched out and incubated for 15 min at room temperature with a mixture of 20 L of reducing agent (500 mmol/L dithiothreitol in doubly distilled water) and of 20 L of internal standard {0.0025 mmol/L d,l-[3,3,3Ј,3Ј,4,4,4Ј,4Ј-2 H 8 ]-homocystine in HCl-acidified water (M r 276.33, isotopic purity Ͼ98%; Cambridge Isotopes Laboratories)}. tHcy was extracted by the addition of 200 L of acetonitrile containing 1 mL/L formic acid and 0.5 mL/L trifluoroacetic acid and vortex-mixing for 1 min. Supernatant (4 L) was loaded onto a Supelcosil TM Cyano column (30 ϫ 3 mm, 3 m bead size) and eluted with a mixture of 700 mL/L acetonitrile-300 mL/L water containing 0.15 mL/L formic acid at a flow rate of 0.4 mL/min. Unattended sample loading was accomplished using a Perkin-Elmer Series 200 autosampler in combination with a Perkin-Elmer LC pump.
A Perkin-Elmer Sciex API 365 LC/MS/MS benchtop triple quadrupole mass spectrometer operating in positive ion mode was used to analyze the eluate. Ionization was achieved with a turbo ion spray device with pneumatically assisted evaporation operating at an ion spray voltage of ϩ5000 V. The TurboIon gas temperature was set to 350°C at a flow rate of 8 L/min. The operating conditions yielded a protonated molecular ion of Hcy (m/z 136.1) in single MS mode ( Fig. 1 ). In MS/MS mode, Hcy yielded a prominent fragment at m/z 90 when a collision gas pressure of 1.067 Pa and a collision energy of 15 eV were applied. Ion transitions monitored in the selected reaction monitoring mode were as follows: 136390 for Hcy and 140394 for the internal standard.
Mass spectral analysis of Hcy-containing serum pretreated with dithiothreitol was performed in the product ion mode of the LC/MS/MS (Fig. 1A) . The most prominent fragment was produced by a neutral loss of formic acid (loss of 46), giving rise to a product ion of m/z 90. This m/z 90 ion was further fragmented, with fragmentation products visible at m/z 73 and m/z 56, which correspond to a neutral loss of ammonia (NH 3 , loss of 17) and hydrogen sulfide (H 2 S, loss of 34), respectively. This fragmentation pattern was confirmed by the product ion spectrum of d,l-[3,3,3Ј,3Ј,4,4,4Ј,4Ј-2 H 8 ]-homocystine, which showed essentially the same fragments with a mass shift of ϩ4 attributable to deuterization of the backbone carbon atoms (data not shown).
Potentially interfering substances were removed by chromatography on a short cyano column before the electrospray, which produced symmetrical peaks for Hcy and its internal standard at virtually identical retention times (Fig. 1B) . The signal-to-noise ratio of a serum containing 5.5 mol/L tHcy measured by HPLC with fluorescence detection was calculated as 60. Thus, the detection limit at a signal-to-noise ratio of 5 was calculated to be 0.5 mol/L. Chromatography and mass spectrometric detection was performed within 3 min, allowing the processing of 20 samples per hour.
For calibration, stabilized hemolysates with low endogenous tHcy were supplemented with d,l-Hcy (M r 135.18; Sigma-Aldrich). The calibration curves for Hcy quantification were obtained by plotting the peak area ratio for the m/z 136390:140394 ion pairs vs the concentration of tHcy (in the range 3.5-60 mol/L). Calibration curves were analyzed by unweighted least-squares linear regression analysis and were linear over the range studied (y ϭ 0.024x ϩ 0.033; S y͉x ϭ 0.039; r ϭ 0.998; n ϭ 6). Within-run precision was determined for a series of 10 spots on paper prepared from samples with low, intermediate, and high concentrations of tHcy; the means Ϯ SD (CV) were 3.5 Ϯ 0.37 mol/L (11%), 8.6 Ϯ 0.85 mol/L (9.9%), and 24.9 Ϯ 2.08 mol/L (8.4%), respectively. Between-run precision was 10.7 Ϯ 1.11 mol/L (10%). Calibrators, qualitycontrol samples, and patient samples were all spotted, eluted, and determined in exactly the same manner.
To determine the accuracy of this method, we analyzed different hemolysates with endogenous tHcy in the low, medium, and upper reference range that were supplemented with different concentrations of d,l-Hcy. The recoveries of added d,l-Hcy were 72-129%, with a total mean Ϯ SD of 105.5% Ϯ 18.3%.
Further validation of the method was done by compar-ing the tHcy values of unselected patients determined by reversed-phase HPLC with fluorometric detection to the LC/MS/MS method. The reference range of tHcy in hemolysates determined by HPLC was Ͻ9 mol/L, well in accordance with previously published results (11 ) .
Comparison of HPLC (x) and LC/MS/MS (y) revealed a correlation coefficient r ϭ 0.9296 with a slope of 1.17. The y-axis intercept was Ϫ1.62, and the standard deviation of residuals (S y͉x ) was 1.67. The mean Ϯ SD of the HPLC and LC/MS/MS determinations were 7.01 Ϯ 3.58 and 6.60 Ϯ 4.51 mol/L, respectively (n ϭ 79 samples).
In conclusion, we have developed and validated a fast, easy, and reliable method to determine tHcy from small amounts of hemolysate or plasma by stable isotope dilution-tandem mass spectrometry. The method avoids derivatization of the Hcy; instead, a simple solid-phase extraction is performed within minutes from filter cards used for neonatal screening. Except for the deuterated internal standard, no expensive reagents are necessary. Cleaning of the sample is achieved by a short in-line preanalytical chromatography column. The method is suitable for determination in stabilized hemolysates, thereby offering the advantage of sample stability for 48 h at room temperature and preventing the significant increase of tHcy in EDTA plasma if it is not immediately separated from the erythrocytes. Finally, because the turnaround time of the method is Ͻ3 min per sample, it is well suited for clinical trials in which large numbers of samples must be handled daily. The precursor/product ion pairs for unlabeled tHcy and the labeled internal standard were 136390 and 140394, respectively. cps, counts per second; amu, atomic mass units.
